CDKN2A and neoplasm: As tumor cells migrate deeper into the dermis, they acquire additional alterations, including mutations in genes such as PTEN, NOTCH1, and CDKN2A, that contribute to proliferative advantage, immune evasion, and matrix degradation [57].